These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23418385)

  • 21. Usability of an innovative and interactive electronic system for collection of patient-reported data in axial spondyloarthritis: comparison with the traditional paper-administered format.
    Salaffi F; Gasparini S; Ciapetti A; Gutierrez M; Grassi W
    Rheumatology (Oxford); 2013 Nov; 52(11):2062-70. PubMed ID: 23955646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):961-5. PubMed ID: 10229428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring participation in people with spondyloarthritis using the social role participation questionnaire.
    Davis AM; Palaganas MP; Badley EM; Gladman DD; Inman RD; Gignac MA
    Ann Rheum Dis; 2011 Oct; 70(10):1765-9. PubMed ID: 21791450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study.
    Pavy S; Brophy S; Calin A
    J Rheumatol; 2005 Jan; 32(1):80-5. PubMed ID: 15630730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish.
    Pedersen OB; Hansen GO; Svendsen AJ; Ejstrup L; Junker P
    Scand J Rheumatol; 2007; 36(1):22-7. PubMed ID: 17454931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany].
    Brandt J; Westhoff G; Rudwaleit M; Listing J; Zink A; Braun J; Sieper J
    Z Rheumatol; 2003 Jun; 62(3):264-73. PubMed ID: 12827403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.
    Garrett S; Jenkinson T; Kennedy LG; Whitelock H; Gaisford P; Calin A
    J Rheumatol; 1994 Dec; 21(12):2286-91. PubMed ID: 7699630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study.
    Marzo-Ortega H; McGonagle D; O'Connor P; Emery P
    Arthritis Rheum; 2001 Sep; 44(9):2112-7. PubMed ID: 11592375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARCOSPA - Sarcopenia in spondyloarthritis patients.
    Aguiar R; Sequeira J; Meirinhos T; Ambrósio C; Barcelos A
    Acta Reumatol Port; 2014; 39(4):322-6. PubMed ID: 25584619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy.
    Claudepierre P; Sibilia J; Goupille P; Flipo RM; Wendling D; Eulry F; Clerc D; Berthelot JM; Vergne P; Roudot-Thoraval F; Larget-Piet B; Chevalier X
    J Rheumatol; 1997 Oct; 24(10):1954-8. PubMed ID: 9330938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort.
    Chung HY; Machado P; van der Heijde D; D'Agostino MA; Dougados M
    Ann Rheum Dis; 2012 Jun; 71(6):809-16. PubMed ID: 21989541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The BASDAI-D--an instrument to defining disease status in ankylosing spondylitis and related diseases].
    Bönisch A; Ehlebracht-König I
    Z Rheumatol; 2003 Jun; 62(3):251-63. PubMed ID: 12827402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
    Calin A; Garrett S; Whitelock H; Kennedy LG; O'Hea J; Mallorie P; Jenkinson T
    J Rheumatol; 1994 Dec; 21(12):2281-5. PubMed ID: 7699629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
    Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
    Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S).
    Zochling J
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S47-58. PubMed ID: 22588768
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires.
    Van Tubergen A; Debats I; Ryser L; Londoño J; Burgos-Vargas R; Cardiel MH; Landewé R; Stucki G; Van Der Heijde D
    Arthritis Rheum; 2002 Jun; 47(3):242-8. PubMed ID: 12115152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.
    Cronstedt H; Waldner A; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():1-9. PubMed ID: 10503553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovertebral erosions in patients with enteropathic spondyloarthritis.
    Peluso R; DI Minno MN; Bruner V; Soscia E; Castiglione F; Manguso F; Iervolino S; Scarpa R
    J Rheumatol; 2012 Dec; 39(12):2332-40. PubMed ID: 23070989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.
    Calin A; Nakache JP; Gueguen A; Zeidler H; Mielants H; Dougados M
    J Rheumatol; 1999 Apr; 26(4):975-9. PubMed ID: 10229431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis.
    Taylor AL; Balakrishnan C; Calin A
    Arthritis Rheum; 1998 Jun; 41(6):1119-25. PubMed ID: 9627023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.